Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.
This Medicare Advantage insurer leverages proprietary technology to manage care costs. A key insider recently trimmed their stake.
Overview
Andrew Toy, Chief Executive Officer of Clover Health Investments (NASDAQ:CLOV), reported the direct sale of 313,476 shares of Common Stock on July 1, 2026, for a transaction value of ~$1.67 million according to the SEC Form 4 filing.
Transaction value based on SEC Form 4 reported price ($5.32); post-transaction value based on the July 1 closing price ($5.39).
Details
* 1-year performance calculated using July 1st, 2026 as the reference date.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.